Concomitant Use of Oral Anticoagulants With Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events

Documenti analoghi

• Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins
  di: Cheng Chen, et al.
  Pubblicazione: (2024)
• Letter: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
  di: Jiaqi Shen, et al.
  Pubblicazione: (2026)
• Research Communication: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
  di: Lauren Holtslander, et al.
  Pubblicazione: (2025)
• Thinking Three‐Dimensionally: A Self‐ and Externally‐Controlled Approach to Screening for Drug–Drug–Drug Interactions Among High‐Risk Populations
  di: Emily K. Acton, et al.
  Pubblicazione: (2024)
• Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review
  di: Patricia Y. Chu, et al.
  Pubblicazione: (2024)